EUCTR2005-005152-40-IT进行中（未招募）不适用
MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, TRIAL ON ALPHA-LIPOIC ACID FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS ALALS - ALALS
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点目标入组 84 人开始时间: 2006年4月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •PROBABo E PR DEFINITE ALS, AGE BETWEEN 30 AND 70 YEARS, DISEASE DURATION LESS THAN 18 MONTHS
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •FAMILIAL ALS, SERIOUS MEDICAL CONDITIONS, CANCERS
研究者
相似试验
已完成
不适用
MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 12-WEEK FACTORIAL DISTRIBUTION STUDY TO ASSESS THE EFFECTIVENESS OF SCH 58235 10 MG / DAY COADMINISTERED WITH MULTIPLE DOSES OF SIMVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA.PER-024-01SCHERING PLOUGH RESEARCH INSTITUTE,
已完成
不适用
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)-B209 HIV disease resulting in unspecified infectious or parasitic diseaseHIV disease resulting in unspecified infectious or parasitic diseaseB209PER-007-06MERCK SHARP & DOHME PERU S.R.L.,
已完成
不适用
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasPER-030-06BRISTOL MYERS SQUIBB COMPANY,
已完成
不适用
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving ChemotherapyPER-078-05GLAXOSMITHKLINE PERU S.A.,
已完成
不适用
Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-022-06GLAXOSMITHKLINE PERU S.A.,18